Archives

by in
Entry Author Date Location
Elan Breached Tysabri Partnership With Biogen Idec, Federal Judge Says 09/04/09 Boston
Pickett to Relinquish Biogen Idec Board Seat, New Financing for iWalk, Genocea Goes After Vaccine Market, & More Boston-Area Life Sciences News 09/02/09 Boston
Biogen Idec Research Boss Quits Board, Giving Icahn Shot at Pushing R&D Agenda 08/26/09 Boston
In Aftermath of Proxy Fight Amylin Pharmaceuticals Investor Expresses Concern Over Empty Board Chair Seat 08/07/09 San Diego
Elan Hits Biogen Idec with Lawsuit to Protect Tysabri Deal with J&J 08/06/09 Boston
VC Biotech Funding Rebounds, Biogen Idec Co-Founder Resigns From Board, Pathway Genomics Debuts $250 Personal Genome Test, & More San Diego Life Sciences News 07/23/09 San Diego
Replacing Phil Sharp Will Be Up to Biogen’s Board 07/20/09 Boston
Biotech Pioneer Phillip Sharp Retires from Biogen Idec Board 07/16/09 Boston
Icahn Bags Two Biogen Board Seats, Pharma Giants Add $40M to Aileron Coffers, Pulmatrix Proceeds With Tests of Flu-Blocking Aerosol, & More Boston-Area Life Sciences News 06/10/09 Boston
Biogen Idec Confirms Second Icahn Pick Elected to Board of Directors 06/09/09 Boston
Exclusive: Icahn’s Picks For Biogen Idec Board on Why They Think They Won 2 Seats, Who’s Likely Out, and Plans for the Future 06/04/09 Boston
Amylin Dissidents Win Board Seats, Targeted Genetics’ Troubles Raise Gene Therapy Concerns, Celladon Eyes Partnership, & More San Diego Life Sciences News 06/04/09 San Diego
Icahn Nominees Claim Victory on Two of Four Open Seats to Biogen Idec Board, Vote Still Not Official 06/03/09 Boston
Inside the Biogen Idec Shareholder Meeting, Tensions Flare as Icahn Accuses Company of “Hijacking” Vote 06/03/09 Boston
Contentious Biogen Idec Meeting Delayed; Icahn Nominee Objects, Saying “This is Not North Korea” 06/03/09 Boston
Biogen Idec Showdown with Carl Icahn Culminates in Shareholder Vote Today 06/03/09 Boston
Amylin Founder Ted Greene, In Exclusive Interview, Upbeat About Outcome of Proxy Battle 06/02/09 San Diego
Amylin Chairman, Lead Director Ousted as Dissidents Gain Two Board Seats 06/02/09 San Diego
Amylin Pharmaceuticals Gets New Directors (But Who Are They?), Ophthonix and Vical Raise Capital, Metabasis Cuts Back—Again, & More San Diego Life Sciences News 05/28/09 San Diego
Genentech Veteran Takes Agios’ Helm, E8 and MIT Take on Navigenics, Genzyme’s Mipomersen Takes Next Step, Alnylam Takes Advantage of Tekmira Technology, & More Boston-Area Life Sciences News 05/28/09 Boston
Amylin’s Dissident Shareholders Gain Influence on Board 05/27/09 San Diego
Amylin Shareholders Vote Today in Battle to Influence Board 05/27/09 San Diego
Icahn Wins Key Endorsement In Proxy Fight With Biogen Idec 05/26/09 Boston
Shareholder Showdown at Amylin Headquarters 05/26/09 San Diego
Biogen Idec Rebuts Icahn Attack, GlaxoSmithKline Quietly Spins Off Tempero Pharmaceuticals, Knome Launches Cheaper Sequencing Service, & More Boston-Area Life Sciences News 05/20/09 Boston
Icahn Wants to Fix Amylin First, Not Sell on the Cheap, Alex Denner Says 05/19/09 San Diego
Amylin Dissidents Win More Support 05/18/09 San Diego
Amylin Co-Founder Ted Greene Explains His Switch in Proxy Battle 05/18/09 San Diego
Amylin Dissidents Ought to Win Proxy Fight, Influential Advisory Firm Says 05/15/09 San Diego
Icahn’s Plan to Split Up Biogen Idec Would “Destroy Shareholder Value,” Company Says 05/15/09 Boston
Page 3 of 6 « previous page · next page »